We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Anticoagulant-Related Bleeding Risk in Older Persons: Unfounded Fears?—Reply

Malcolm Man-Son-Hing, MD, MSC, FRCPC; Andreas Laupacis, MD, MSC, FRCPC
Arch Intern Med. 2004;164(1):106-107. doi:10.1001/archinte.164.1.107-a.
Text Size: A A A
Published online


In reply

Based on the perception of an unacceptably high risk of major bleeding in many older persons receiving anticoagulant therapy, Dr Pechlaner concludes that many older patients with atrial fibrillation might not derive overall benefit for anticoagulant therapy. A number of references used to support his conclusions are open to critique in the context of today's clinical practice. For example, the study by Beyth et al1 was performed in the 1980s, a time when higher-intensity anticoagulation was the norm. In fact, the mean international normalized ratios of persons in this study were greater than 3.0, a level clearly shown to increase bleeding risk without providing incremental stroke protection benefit. Therefore, the estimates of bleeding risk from this study are likely higher than that found in current practice, with the recommended target international normalized ratio being 2.5 (range, 2.0-3.0), and the clinical usefulness of their bleeding risk stratification scheme is open to question. Also, in the cost-effectiveness study of the value of anticoagulant therapy in the oldest old (up to 100 years of age) by Desbiens,2 a few questionable assumptions about the risk of bleeding (especially hemorrhagic stroke) in the oldest age groups were made. Desbiens based the extrapolation of intracranial bleeding risk in older persons on data from the Stroke Prevention in Atrial Fibrillation II study.3 The anticoagulation intensity (international normalized ratio, 2.0-4.5) of this study was also higher than what is used presently, leading to a bleeding rate higher than that found in other atrial fibrillation studies.4 Therefore, the extrapolated estimates by Desbiens of intracranial bleeding risk in older age groups taking warfarin (including a 10% yearly risk in persons 100 years old) appear to be a serious overestimation. Furthermore, the robustness of his analysis is compromised when sensitivity analysis showed that the model was quite sensitive to variations in this parameter. Finally, while these studies suggest an increase in bleeding risk as one ages, other studies5,6 have not found this phenomenon, though they too have some methodological difficulties.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Clinical Scenario

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Clinical Scenario